Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Prostatic Escherichia coli inf...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Prostatic Escherichia coli infection drives CCR2-dependent recruitment of fibrocytes and collagen production

Prostatic Escherichia coli infection drives CCR2-dependent recruitment of fibrocytes and collagen production

Bibliographic Details
Main Authors: Brandon R. Scharpf, Hannah Ruetten, Jaskiran Sandhu, Kyle A. Wegner, Sneha Chandrashekar, Olivia Fox, Anne E. Turco, Clara Cole, Lisa M. Arendt, Douglas W. Strand, Chad M. Vezina
Format: Article
Language:English
Published: The Company of Biologists 2025-01-01
Series:Disease Models & Mechanisms
Subjects:
prostate
fibrosis
myofibroblast
fibrocyte
lutd
ccr2
Online Access:http://dmm.biologists.org/content/18/1/DMM052012
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://dmm.biologists.org/content/18/1/DMM052012

Similar Items

  • Curcumin Treatment Suppresses CCR7 Expression and the Differentiation and Migration of Human Circulating Fibrocytes
    by: Xu-yan Fu, et al.
    Published: (2015-01-01)
  • Fibrocytes: A Critical Review and Practical Guide
    by: James W. Reinhardt, et al.
    Published: (2021-12-01)
  • Depletion of Bone Marrow-Derived Fibrocytes Attenuates TAA-Induced Liver Fibrosis in Mice
    by: Felix Hempel, et al.
    Published: (2019-10-01)
  • Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis
    by: P. Heukels, et al.
    Published: (2018-05-01)
  • Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity
    by: Seidai Sato, et al.
    Published: (2017-09-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs